IShares Pharmaceuticals Stock Options
| IHE Etf | USD 68.77 0.74 1.09% |
IShares Pharmaceuticals' latest option contracts expiring on October 17th 2025 are carrying combined implied volatility of 0.17 with a put-to-call open interest ratio of 9.75 over 25 outstanding agreements suggesting investors are buying way more puts than calls on contracts expiring on October 17th 2025.
Open Interest Against October 17th 2025 Option Contracts
2025-10-17
The chart above shows IShares Pharmaceuticals' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. IShares Pharmaceuticals' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for IShares Pharmaceuticals' option, there is no secondary market available for investors to trade.
In The Money vs. Out of Money Option Contracts on IShares Pharmaceuticals
Analyzing IShares Pharmaceuticals' in-the-money options over time can help investors to take a profitable long position in IShares Pharmaceuticals regardless of its overall volatility. This is especially true when IShares Pharmaceuticals' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money IShares Pharmaceuticals' options could be used as guardians of the underlying stock as they move almost dollar for dollar with IShares Pharmaceuticals' stock while costing only a fraction of its price.
IShares Pharmaceuticals' stock options are financial instruments that give investors the right to buy or sell shares of iShares Pharmaceuticals common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell IShares stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If IShares Pharmaceuticals' stock price goes up or down, the stock options follow.
iShares Pharmaceuticals In The Money Call Balance
When IShares Pharmaceuticals' strike price is surpassing the current stock price, the option contract against iShares Pharmaceuticals ETF stock is said to be in the money. When it comes to buying IShares Pharmaceuticals' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on iShares Pharmaceuticals ETF are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
IShares Current Options Market Mood
IShares Pharmaceuticals' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps IShares Etf's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Using current IShares Pharmaceuticals' option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.
Rule 16 of the current IShares contract
Base on the Rule 16, the options market is currently suggesting that iShares Pharmaceuticals ETF will have an average daily up or down price movement of about 0.0106% per day over the life of the 2025-10-17 option contract. With IShares Pharmaceuticals trading at USD 68.77, that is roughly USD 0.007307. If you think that the market is fully incorporating IShares Pharmaceuticals' daily price movement you should consider buying iShares Pharmaceuticals ETF options at the current volatility level of 0.17%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Purchasing IShares Pharmaceuticals options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" IShares calls. Remember, the seller must deliver iShares Pharmaceuticals ETF stock to the call owner when a call is exercised.
IShares Pharmaceuticals Option Chain
When IShares Pharmaceuticals' strike price is surpassing the current stock price, the option contract against iShares Pharmaceuticals ETF stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
IShares Pharmaceuticals' option chain is a display of a range of information that helps investors for ways to trade options on IShares. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for IShares. It also shows strike prices and maturity days for a IShares Pharmaceuticals against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | IHE251017C00076000 | 0 | 76.0 | 0.0 - 0.3 | 0.3 | |
Call | IHE251017C00075000 | 1 | 75.0 | 0.0 - 0.35 | 0.35 | Out |
Call | IHE251017C00074000 | 1 | 74.0 | 0.0 - 0.95 | 0.95 | Out |
Call | IHE251017C00073000 | 0 | 73.0 | 0.0 - 1.05 | 1.05 | |
Call | IHE251017C00072000 | 0 | 72.0 | 0.0 - 1.3 | 1.3 | |
Call | IHE251017C00071000 | 0 | 71.0 | 0.0 - 1.6 | 1.6 | |
Call | IHE251017C00070000 | 0 | 70.0 | 0.0 - 1.9 | 1.9 | |
Call | IHE251017C00069000 | 1 | 69.0 | 1.75 - 2.4 | 1.75 | Out |
Call | IHE251017C00068000 | 0 | 68.0 | 1.1 - 2.95 | 1.1 | |
Call | IHE251017C00067000 | 0 | 67.0 | 1.55 - 3.7 | 1.55 | In |
Call | IHE251017C00066000 | 2 | 66.0 | 2.25 - 4.4 | 2.25 | In |
Call | IHE251017C00065000 | 1 | 65.0 | 3.1 - 5.1 | 3.1 | In |
Call | IHE251017C00056000 | 2 | 56.0 | 11.9 - 13.2 | 11.6 | In |
Put | IHE251017P00076000 | 0 | 76.0 | 7.2 - 10.0 | 7.2 | In |
Put | IHE251017P00075000 | 0 | 75.0 | 6.3 - 9.0 | 6.3 | In |
Put | IHE251017P00074000 | 0 | 74.0 | 5.3 - 8.1 | 5.3 | In |
Put | IHE251017P00073000 | 0 | 73.0 | 4.4 - 7.3 | 4.4 | In |
Put | IHE251017P00072000 | 0 | 72.0 | 3.7 - 6.5 | 3.7 | In |
Put | IHE251017P00071000 | 0 | 71.0 | 2.6 - 4.3 | 2.6 | In |
Put | IHE251017P00070000 | 0 | 70.0 | 1.55 - 3.5 | 1.55 | In |
Put | IHE251017P00069000 | 0 | 69.0 | 0.95 - 3.0 | 0.95 | In |
Put | IHE251017P00068000 | 0 | 68.0 | 1.6 - 2.75 | 1.6 | |
Put | IHE251017P00067000 | 1 | 67.0 | 0.0 - 2.35 | 1.19 | Out |
Put | IHE251017P00064000 | 2 | 64.0 | 0.0 - 1.55 | 0.95 | Out |
Put | IHE251017P00058000 | 75 | 58.0 | 0.15 - 0.5 | 0.5 | Out |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in iShares Pharmaceuticals ETF. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
The market value of iShares Pharmaceuticals is measured differently than its book value, which is the value of IShares that is recorded on the company's balance sheet. Investors also form their own opinion of IShares Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is IShares Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IShares Pharmaceuticals' market value can be influenced by many factors that don't directly affect IShares Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IShares Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if IShares Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IShares Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.